Handok will be reborn as health innovator

Under the spirit of ‘The Health Innovator’ this year despite economic downturn, Handok will continue to expand its presence in the domestic market through joint development of new products and licensing with advanced pharmaceutical and bio-venture companies in Japan, Europe and the United States, said Kim Young-jin, chairman of Handok Pharm chairman

“This expansion will be based our clinicl...